Correction to: Scientific Reports https://doi.org/10.1038/s41598-019-39510-w, published online 28 February 2019
In the original version of this Article, Giorgio Valabrega was incorrectly affiliated with ‘Department of Medical Sciences, University of Torino, Torino, Italy’. The correct affiliation is listed below.
Candiolo Cancer Institute, FPO - IRCCS - Candiolo (TO) 10060, ITALY
This error has now been corrected in the PDF and HTML versions of the Article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Costamagna, A., Rossi Sebastiano, M., Natalini, D. et al. Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents. Sci Rep 9, 17729 (2019). https://doi.org/10.1038/s41598-019-54252-5
Published:
DOI: https://doi.org/10.1038/s41598-019-54252-5
